Novo Nordisk Rebrands as ‘Novo’: Stock Falls as Company Aims GLP-1s at Consumers
Novo Nordisk (NVO) rebranded itself as merely “Novo” on Monday, unveiling a brand new company tradition framework as the Danish drugmaker tries to shut a widening hole with rival Eli Lilly within the weight problems drug market. CEO Mike Doustdar instructed CNBC the rebrand and tradition shift are a part of the identical package deal…
